These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 28783870)
21. Accelerated wound healing in a diabetic rat model using decellularized dermal matrix and human umbilical cord perivascular cells. Milan PB; Lotfibakhshaiesh N; Joghataie MT; Ai J; Pazouki A; Kaplan DL; Kargozar S; Amini N; Hamblin MR; Mozafari M; Samadikuchaksaraei A Acta Biomater; 2016 Nov; 45():234-246. PubMed ID: 27591919 [TBL] [Abstract][Full Text] [Related]
22. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis. Theiss HD; Vallaster M; Rischpler C; Krieg L; Zaruba MM; Brunner S; Vanchev Y; Fischer R; Gröbner M; Huber B; Wollenweber T; Assmann G; Mueller-Hoecker J; Hacker M; Franz WM Stem Cell Res; 2011 Nov; 7(3):244-55. PubMed ID: 21752744 [TBL] [Abstract][Full Text] [Related]
23. Dynamic multiphoton imaging of acellular dermal matrix scaffolds seeded with mesenchymal stem cells in diabetic wound healing. Chu J; Shi P; Deng X; Jin Y; Liu H; Chen M; Han X; Liu H J Biophotonics; 2018 Jul; 11(7):e201700336. PubMed ID: 29575792 [TBL] [Abstract][Full Text] [Related]
25. Stromal cell-derived factor-1 receptor CXCR4-overexpressing bone marrow mesenchymal stem cells accelerate wound healing by migrating into skin injury areas. Yang D; Sun S; Wang Z; Zhu P; Yang Z; Zhang B Cell Reprogram; 2013 Jun; 15(3):206-15. PubMed ID: 23713431 [TBL] [Abstract][Full Text] [Related]
26. Recruitment of transplanted dermal multipotent stem cells to sites of injury in rats with combined radiation and wound injury by interaction of SDF-1 and CXCR4. Zong ZW; Cheng TM; Su YP; Ran XZ; Shen Y; Li N; Ai GP; Dong SW; Xu H Radiat Res; 2008 Oct; 170(4):444-50. PubMed ID: 19024651 [TBL] [Abstract][Full Text] [Related]
27. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells. Yoshida D; Koketshu K; Nomura R; Teramoto A J Neurooncol; 2010 Oct; 100(1):51-64. PubMed ID: 20309720 [TBL] [Abstract][Full Text] [Related]
29. The SDF-1/CXCR4 chemokine axis in uveal melanoma cell proliferation and migration. Bi J; Li P; Li C; He J; Wang Y; Zhang H; Fan X; Jia R; Ge S Tumour Biol; 2016 Mar; 37(3):4175-82. PubMed ID: 26490988 [TBL] [Abstract][Full Text] [Related]
30. SDF-1 promotes endochondral bone repair during fracture healing at the traumatic brain injury condition. Liu X; Zhou C; Li Y; Ji Y; Xu G; Wang X; Yan J PLoS One; 2013; 8(1):e54077. PubMed ID: 23349789 [TBL] [Abstract][Full Text] [Related]
31. AMD3100 and G-CSF disrupt the cross-talk between leukemia cells and the endosteal niche and enhance their sensitivity to chemotherapeutic drugs in biomimetic polystyrene scaffolds. Shen ZH; Zeng DF; Kong PY; Ma YY; Zhang X Blood Cells Mol Dis; 2016 Jul; 59():16-24. PubMed ID: 27282562 [TBL] [Abstract][Full Text] [Related]
32. Effect of SDF-1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury. Li J; Guo W; Xiong M; Han H; Chen J; Mao D; Tang B; Yu H; Zeng Y Int J Mol Med; 2015 Nov; 36(5):1205-14. PubMed ID: 26398409 [TBL] [Abstract][Full Text] [Related]
33. Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells. Dar A; Schajnovitz A; Lapid K; Kalinkovich A; Itkin T; Ludin A; Kao WM; Battista M; Tesio M; Kollet O; Cohen NN; Margalit R; Buss EC; Baleux F; Oishi S; Fujii N; Larochelle A; Dunbar CE; Broxmeyer HE; Frenette PS; Lapidot T Leukemia; 2011 Aug; 25(8):1286-1296. PubMed ID: 21494253 [TBL] [Abstract][Full Text] [Related]
34. Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway. Xia R; Xu G; Huang Y; Sheng X; Xu X; Lu H Life Sci; 2018 May; 201():111-120. PubMed ID: 29604270 [TBL] [Abstract][Full Text] [Related]
35. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. Hatse S; Princen K; Bridger G; De Clercq E; Schols D FEBS Lett; 2002 Sep; 527(1-3):255-62. PubMed ID: 12220670 [TBL] [Abstract][Full Text] [Related]
36. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis. Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944 [TBL] [Abstract][Full Text] [Related]
37. Modulation of stromal cell-derived factor-1/CXC chemokine receptor 4 axis enhances rhBMP-2-induced ectopic bone formation. Wise JK; Sumner DR; Virdi AS Tissue Eng Part A; 2012 Apr; 18(7-8):860-9. PubMed ID: 22035136 [TBL] [Abstract][Full Text] [Related]
38. Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair. Toupadakis CA; Wong A; Genetos DC; Chung DJ; Murugesh D; Anderson MJ; Loots GG; Christiansen BA; Kapatkin AS; Yellowley CE J Orthop Res; 2012 Nov; 30(11):1853-9. PubMed ID: 22592891 [TBL] [Abstract][Full Text] [Related]
39. Upregulated stromal cell-derived factor 1 (SDF-1) expression and its interaction with CXCR4 contribute to the pathogenesis of severe pterygia. Kim KW; Park SH; Lee SH; Kim JC Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7198-206. PubMed ID: 24114538 [TBL] [Abstract][Full Text] [Related]
40. The inhibitory effect of Phα1β toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor. da Silva Junior CA; de Castro Junior CJ; Pereira EMR; Binda NS; da Silva JF; do Nascimento Cordeiro M; Diniz DM; Cecilia FS; Ferreira J; Gomez MV Pharmacol Rep; 2020 Feb; 72(1):47-54. PubMed ID: 32016848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]